Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Precision BioSciences, Inc. (DTIL)
Last precision biosciences, inc. earnings: 11/12 07:15 am
Check Earnings Report
Company Research
Source: Business Wire
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that new preclinical study data supporting the potential safety and long-term efficacy of PBGENE-DMD has been selected as a poster presentation at the upcoming 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference taking place March 8-11 in Orlando, Florida.Details of the presentation:Abstract title: PBGENE-DMD gene editing treatment leads to safe and long-term functional improvement in humanized DMD-disease mouse modelPublication number: 142MType of presentation: Poster presentationAuthors: Adam Mischler, Whitney Lewis, Wendy Shoop, Traci Reddick, Dan Nazarenko, Nicole W. Heard, Ben Morris, Haley Grimason, Krsna Rangarajan, Cheng-Wei Wang, Kalpana Kodi, Dominique Burgess, Katie Poe, Gary Owens, Jeff Smith, Cassandr
Show less
Read more
Impact Snapshot
Event Time:
DTIL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DTIL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DTIL alerts
High impacting Precision BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
DTIL
News
- Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare ConferenceBusiness Wire
- iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA SubmissionBusiness Wire
- Precision BioSciences, Inc. (DTIL) Shareholder/Analyst Call Transcript [Seeking Alpha]Seeking Alpha
- Precision BioSciences (DTIL) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
DTIL
Earnings
- 3/12/26 - Beat
DTIL
Sec Filings
- 4/8/26 - Form ARS
- 4/8/26 - Form DEFA14A
- 4/8/26 - Form DEF
- DTIL's page on the SEC website